TFF Pharmaceuticals Inc. (TFFP)
0.07
-0.09 (-56.98%)
At close: Dec 12, 2024, 9:00 PM
undefined% (undefined)
| Bid | 0.13 |
| Market Cap | 288.80K |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -5.5 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.14 |
| Volume | 11,020,032 |
| Avg. Volume (20D) | 1,656,152 |
| Open | 0.09 |
| Previous Close | 0.16 |
| Day's Range | 0.06 - 0.09 |
| 52-Week Range | 0.06 - 11.00 |
| Beta | undefined |
About TFFP
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II c...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 25, 2019
Employees 19
Stock Exchange NASDAQ
Ticker Symbol TFFP
Website https://www.tffpharma.com
Analyst Forecast
According to 1 analyst ratings, the average rating for TFFP stock is "Buy." The 12-month stock price forecast is $44, which is an increase of 67592.31% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
TFF Pharmaceuticals Inc. is scheduled to release its earnings on Mar 27, 2025,
during market hours.
Analysts project revenue of $200.00K, reflecting a 74.94% YoY growth and earnings per share of -0.73, making a -63.68% decrease YoY.
Analysts project revenue of $200.00K, reflecting a 74.94% YoY growth and earnings per share of -0.73, making a -63.68% decrease YoY.
2 months ago ·
Source
-76.49%
TFF Pharmaceutical shares are trading lower after ...
Unlock content with
Pro Subscription
2 months ago ·
Source
-4.76%
TFF Pharmaceutical shares are trading lower after the company announced it will wind down its operations.
